A number of biotech-related stocks were down pre-market after announcing plans for public offerings.
Former hedge funder and biotech CEO Martin Shkreli finds himself in limbo as a criminal jury now decides if allegations of fraud will put him in orange coveralls.
Cytori Therapeutics stock is sinking after the biotech company priced a stock offering at steep discount.
Here's how biotech and healthcare stocks are moving ahead of market's open.
Stocks with insider trader activity include SUNE, NRIM and CYTX